ArticleLiver cancer2025

Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study.

Yoon Jun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.